Skip to main content
Fig. 4. | BMC Microbiology

Fig. 4.

From: Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011

Fig. 4.

Treatment with LPC alters the multi-lobed phenotype of C. caviae infection. a Increasing concentrations of LPC (in μg/mL) results in diminished C. caviae inclusion compartments and few, large ABs as visualized by DAPI. b Treatment of LPC (1.92 μg/mL) on cells dually infected with C. trachomatis L2 (Ct) and C. caviae (Cc) did not allow for the formation of mixed-species inclusions. Scale bar is 10 μm

Back to article page